CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-26 | James Andrea S. Chief Financial Officer | Option exercise · Restricted Stock Units | −28,302 | 84,905 | ||
| 2026-03-26 | Liu James Yang VP ACCT, Cntlr, Treasurer, PAO | Option exercise | +6,289 | 6,289 | ||
| 2026-03-26 | Liu James Yang VP ACCT, Cntlr, Treasurer, PAO | Shares withheld for taxes | −2,578 | $4.11 | $11K | 3,711 |
| 2026-03-26 | Liu James Yang VP ACCT, Cntlr, Treasurer, PAO | Option exercise · Restricted Stock Units | −6,289 | 12,578 | ||
| 2026-03-26 | Riggs Josh CEO and President | Option exercise | +47,170 | 50,675 | ||
| 2026-03-26 | Riggs Josh CEO and President | Shares withheld for taxes | −12,310 | $4.11 | $51K | 38,365 |
| 2026-03-26 | Riggs Josh CEO and President | Option exercise · Restricted Stock Units | −47,170 | 141,509 | ||
| 2026-02-10 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +521,739 | $5.75 | $3.0M | 11,931,839 |
| 2026-02-10 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | 11,931,839 | ||
| 2025-10-31 | James Andrea S. Chief Financial Officer | Option exercise | +50,000 | 201,231 | ||
| 2025-10-31 | James Andrea S. Chief Financial Officer | Shares withheld for taxes | −12,175 | $6.01 | $73K | 189,056 |
| 2025-10-31 | James Andrea S. Chief Financial Officer | Option exercise · Restricted Stock Units | −50,000 | 50,000 | ||
| 2025-10-31 | James Andrea S. Chief Financial Officer | Option exercise | +50,000 | 201,231 | ||
| 2025-10-31 | James Andrea S. Chief Financial Officer | Returned to the company · Restricted Stock Units | +50,000 | 50,000 | ||
| 2025-09-28 | Liu James Yang VP ACCT, Cntlr, Treasurer, PAO | Grant or award · Option to Purchase Common Stock | +18,000 | 18,000 | ||
| 2025-09-28 | James Andrea S. Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +235,000 | 235,000 | ||
| 2025-09-28 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +400,000 | 400,000 | ||
| 2025-07-01 | Arno Andrew Director | Grant or award | +55,000 | 136,554 | ||
| 2025-07-01 | SILVERMAN LOU Director | Grant or award | +35,000 | 36,564 | ||
| 2025-07-01 | Last Andrew J. Director | Grant or award | +35,000 | 39,509 |
Page 2 of 12 · 222 trades